6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow Lidocaine patch 1.8%: new trials by email Literature Review of Lidocaine patch 1.8% trials Research Report on Lidocaine patch 1.8%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects lidocaine topical system 1.8%, lidocaine patch 5% - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 24 | 2018-09-07 | 2024-04-24 |
| Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects Lidocaine patch 1.8%, Lidocaine patch 5%, Lidocaine medicated plaster 5% - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 47 | 2017-02-14 | 2020-03-24 |
| Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects Lidocaine topical system 1.8%, Lidocaine patch 5% - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 54 | 2016-09-28 | 2019-11-04 |
| Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise Lidocaine topical system 1.8% - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 12 | 2016-01-08 | 2024-05-23 |
| Adhesion of Lidocaine Topical System 1.8% Lidocaine topical system 1.8% - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 54 | 2015-12-01 | 2020-03-18 |
| Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects Lidocaine patch 1.8%, Lidocaine 5% patch, Lidocaine 2% Injectable Solution - Healthy | Phase 1 | Completed | Scilex Pharmaceuticals, Inc. | 58 | 2014-04-28 | 2024-05-23 |
Scilex Pharmaceuticals, Inc. (6)
United States (2)
Phillip LaStella, MD (3) · Anthony Godfrey, PharmD (1) · John Peterson, PharmD, RPh (1) · Patrick Luger, MD (1)